Jafron Presented at ESICM 2017

time :  2017-09-26

On the 30th annual congress of ESICM at Vienna, September 25th 2017, Prof. Claudio Ronco introduced RRT therapy in post surgery or sepsis induced kidney dysfunction, and affirmed the efficacy of hemoperfusion in cytokines removal and ICU outcome.

He recommended that 1) strategies must be based on physiological principles maintaining hemodynamics and avoiding nephrotoxins, 2) RRT techniques must be used according to specific indications and timing of application. Jafron HA330 was cited by Pro. Ronco for cytokines removal in ESICM 2017, with support from physicians all over the world, Jafron is expected to open a promising market globally.